Allergan Unanimously Rejects Revised Valeant Bid

June 10 (Bloomberg) -- Bloomberg’s Betty Liu reports that Allergan’s board has unanimously rejected an improved offer from Valeant, claiming it undervalues the company. She speaks on Bloomberg Television’s “In The Loop.”
Ross: Referendum Doesn't Change Greece's Fundamentals
50:23 - U.S. billionaire Wilbur Ross, chairman and chief executive officer of WL Ross & Co., talks about Greece's vote against yielding to further austerity demanded by creditors. He speaks with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)
  • Malaysia PM Caught Up in 1MDB Money Trail Probe
  • Merkel to Meet Hollande for Response to Greece
  • Euro Lower Monday as Greece Votes No